LH and FSH are two of the most commonly ordered reproductive hormones, yet they are also two of the easiest to misunderstand. A lab report may show a number beside each one, but those numbers do not speak for themselves. Their meaning depends on age, sex, cycle timing, symptoms, medications, and the reason the test was ordered in the first place.
That is why the same FSH result can be reassuring in one person, expected in another, and concerning in someone else. The same is true for LH. In women, these hormones help coordinate follicle growth, ovulation, and hormone production across the menstrual cycle. In men, they help regulate testosterone production and sperm development. In both cases, they are best understood as signals in a wider hormone network, not as isolated verdicts on fertility.
This article breaks down what LH and FSH do, how they change, what patterns can suggest, and where these tests are helpful, limited, or easily misread.
Essential Insights
- LH and FSH help explain ovulation, ovarian function, testosterone signaling, and sperm production, but they are rarely useful as standalone numbers.
- In women, cycle timing matters because LH and FSH shift naturally across the month, especially around ovulation.
- A high or low result does not automatically diagnose infertility, PCOS, or menopause without the rest of the clinical picture.
- Hormonal contraception, pregnancy, recent illness, and irregular cycles can make interpretation less straightforward.
- A practical way to use these tests is to pair them with symptoms, cycle day, estradiol or testosterone, and a clear question such as ovulation, amenorrhea, low testosterone, or fertility workup.
Table of Contents
- What LH and FSH do
- How levels change across the cycle
- What they can and cannot say about fertility
- Patterns seen in PCOS, POI, and hypothalamic suppression
- What LH and FSH mean in men
- When to test and how to interpret results wisely
What LH and FSH do
LH stands for luteinizing hormone. FSH stands for follicle-stimulating hormone. Both are made in the pituitary gland, but they are controlled higher up by the hypothalamus through pulses of gonadotropin-releasing hormone. In practical terms, they are messenger hormones. They do not do all the reproductive work themselves. Instead, they signal the ovaries or testes to do it.
In women, FSH mainly helps recruit and mature ovarian follicles. Early in the cycle, it supports the growth of follicles that contain eggs. As follicles develop, they produce estradiol and inhibin, which then feed back to the brain and help shape what happens next. LH supports steroid hormone production in the ovary and becomes especially important as ovulation approaches. The well-known “LH surge” is the sharp rise that helps trigger ovulation and later supports the corpus luteum, which produces progesterone after the egg is released.
In men, the same hormones act on different target cells. LH stimulates the Leydig cells in the testes to produce testosterone. FSH acts mainly on Sertoli cells and supports spermatogenesis, the process of making sperm. That is why LH is often discussed alongside testosterone, while FSH is often discussed alongside semen analysis and sperm production.
This is also why LH and FSH are rarely interpreted alone. They are part of a loop. In women, estradiol, progesterone, and inhibin all affect them. In men, testosterone and inhibin B influence the feedback pattern. If the gonads are not responding properly, the pituitary may signal harder and LH or FSH may rise. If the problem starts in the pituitary or hypothalamus, LH and FSH may stay low or inappropriately normal even when sex hormone levels are low.
That broader loop explains why LH and FSH are useful across very different questions:
- Is ovulation likely happening?
- Is the ovary responding normally?
- Does the pattern suggest menopause or primary ovarian insufficiency?
- Is there evidence of hypothalamic or pituitary suppression?
- In men, is low testosterone more likely testicular or central?
- Is impaired sperm production part of the picture?
The key is not to treat them like universal fertility scores. They are more like directional clues about where the reproductive system is under strain. That is especially important because people often search these hormones after one odd lab result, when what matters most is the pattern over time and the clinical context around it.
If your main question is whether ovulation is happening at all, it may also help to compare lab results with real-world signs of ovulation and fertile timing rather than relying on one number alone.
How levels change across the cycle
One reason LH and FSH confuse people is that there is no single “normal” value that means the same thing all month. In cycling women, both hormones rise and fall across the menstrual cycle, and the timing of the blood draw can change the interpretation substantially.
In the early follicular phase, often around cycle days 2 to 5, FSH and LH are usually measured at a relatively low baseline. This is the window most clinicians use when they want a stable reference point for ovarian function. FSH at this stage is often paired with estradiol because estradiol can sometimes suppress FSH and make ovarian reserve look better on paper than it really is. That is one reason cycle-day testing is often discussed rather than random testing.
As the dominant follicle develops, estradiol rises. When estradiol remains high long enough, feedback changes direction and triggers the midcycle LH surge. That surge is what ovulation predictor kits are trying to detect in urine. It does not mean the egg has already been released. It signals that ovulation is likely approaching, often within roughly a day or so. FSH also rises around ovulation, but LH is the dramatic peak most people hear about.
After ovulation, in the luteal phase, LH and FSH typically settle again while progesterone becomes the more informative hormone. That means a random LH or FSH value taken late in the cycle can be much less helpful if the real question is ovarian reserve or baseline gonadotropin signaling.
This timing issue becomes even trickier when cycles are irregular. In people with long, unpredictable cycles, PCOS, perimenopause, recent pregnancy, or recent stopping of hormonal contraception, it may be hard to know what “day 3” really represents biologically. A lab drawn on calendar day 3 after a long anovulatory stretch does not always mean the same thing as cycle day 3 in a clearly ovulatory cycle.
Hormonal contraception changes things too. Combined pills, patches, rings, and some other hormonal methods suppress the normal ovarian cycle and often make LH and FSH much less useful for interpreting natural ovulatory function. Pregnancy, breastfeeding, major weight loss, and high training load can also shift the pattern significantly.
This is why clinicians often start with a basic question before ordering the test: what decision is the result supposed to help make? If the goal is to assess ovarian reserve, timing matters. If the goal is to investigate amenorrhea, the whole hormone picture matters more than an isolated cycle-day rule. If the goal is to confirm a likely LH surge, blood testing may not even be the most practical tool.
For readers trying to sort out exactly when hormone labs are most informative, a guide to cycle timing and the best time to test hormones can prevent a lot of avoidable confusion.
What they can and cannot say about fertility
LH and FSH can tell you something about the reproductive system, but they cannot tell you everything about fertility. This is one of the most important limits to understand.
FSH is often discussed in the context of ovarian reserve because higher early-follicular-phase FSH can suggest the ovary is requiring more stimulation from the pituitary. In plain language, it can be a sign that the ovary is becoming less responsive. That is why FSH has long been used as part of fertility evaluation, particularly when diminished ovarian reserve is a concern.
But there is an important caveat: ovarian reserve markers do not equal overall fertility in a simple, one-to-one way. A higher FSH may predict a lower egg yield in response to ovarian stimulation, yet it does not neatly predict whether someone will conceive naturally in a given future month. Age, ovulation, sperm factors, tubal status, endometriosis, uterine factors, and timing still matter. Fertility is not a single hormone problem.
LH is even easier to overread. A single LH value is rarely a reliable summary of fertility. It can be useful when interpreted within the cycle or alongside other hormones, but it is not a standalone egg-quality test or a universal ovulation score. Outside specific settings, it is often less informative than people expect.
This helps explain why many fertility workups include more than LH and FSH alone. Depending on the situation, clinicians may also consider:
- estradiol
- anti-Müllerian hormone
- progesterone after ovulation
- prolactin
- TSH
- semen analysis
- pelvic ultrasound
- tubal evaluation
This matters especially for people who receive one “abnormal” FSH result and assume it means future pregnancy is unlikely. That leap is often too big. FSH can offer useful information, but it is only one part of a wider story. The same is true for low-normal results. A reassuring FSH does not rule out infertility if ovulation, sperm, tubal, or uterine issues are present.
It is also worth separating ovarian reserve from egg quality. They overlap, but they are not identical. Reserve is more about quantity and response. Egg quality is driven strongly by age and cannot be fully captured by LH or FSH.
If your main question is whether reserve markers are being asked to do too much, it may help to read more about what ovarian reserve tests can and cannot really tell you. That wider lens often makes LH and FSH results feel less alarming and more useful.
The most accurate way to think about these hormones is this: they can help frame fertility evaluation, but they do not settle it on their own.
Patterns seen in PCOS, POI, and hypothalamic suppression
LH and FSH become especially useful when symptoms point toward a broader syndrome rather than a simple timing question. Three common examples are PCOS, primary ovarian insufficiency, and hypothalamic suppression.
In PCOS, people often hear about a high LH to FSH ratio. This pattern can happen, especially in classic presentations, because altered GnRH pulsatility can favor LH secretion. But the ratio is not diagnostic by itself. Some people with PCOS do not have an elevated ratio, and some people without PCOS can show a similar pattern. That is why current diagnosis relies more on the overall clinical picture: ovulatory dysfunction, hyperandrogenism, and ovarian morphology or, in selected settings, related markers. LH and FSH may support the interpretation, but they do not define the condition by themselves. If irregular cycles and androgen symptoms are also present, it may help to compare your labs with the broader features of PCOS symptoms and presentation patterns.
In primary ovarian insufficiency, or POI, the pattern is different. The ovary is no longer responding as expected, so the pituitary increases stimulation. FSH tends to rise, often clearly, and the elevation usually has to be confirmed rather than judged from a single borderline test. Estradiol is often low, and symptoms may include irregular or missed periods, hot flashes, night sweats, vaginal dryness, or infertility. In younger patients, this pattern deserves prompt attention because it has implications beyond fertility, including bone and cardiovascular health.
In hypothalamic suppression or certain pituitary causes of amenorrhea, LH and FSH may be low or inappropriately normal rather than high. This can happen with low energy availability, significant weight loss, intense exercise, high stress, chronic illness, or pituitary disease. In this situation, the brain is not sending a strong enough reproductive signal, so the gonads are under-stimulated. Estradiol or testosterone may also be low, but LH and FSH do not rise because the problem is upstream.
These different patterns matter because they point in opposite directions:
- High gonadotropins can suggest the gonads are failing to respond.
- Low or normal gonadotropins with low sex steroids can suggest a central problem.
- Mixed or mild patterns require context and sometimes repeat testing.
This is why LH and FSH are often better at sorting categories than at predicting one precise outcome. They help ask where the signal is breaking down. They do not replace the need for history, symptoms, ultrasound, repeat labs, or broader endocrine evaluation when needed.
What LH and FSH mean in men
LH and FSH are not just female fertility hormones. In men, they are central to testosterone production and sperm development, which makes them important in the evaluation of infertility, low testosterone symptoms, or delayed or disrupted pubertal development.
LH mainly stimulates the Leydig cells of the testes to produce testosterone. FSH works more on Sertoli cells and helps support spermatogenesis. Because of that division of labor, LH is often interpreted alongside total testosterone, while FSH is especially useful when semen quality or sperm production is a concern.
A few broad patterns are particularly helpful:
- High LH with low testosterone can suggest primary testicular dysfunction, meaning the testes are not responding well to pituitary signaling.
- Low or normal LH with low testosterone can suggest a central problem involving the pituitary or hypothalamus.
- High FSH may point toward impaired sperm production, especially when semen analysis is abnormal.
- Low or normal FSH and LH in someone with low testosterone or infertility can suggest suppression higher up in the hormone pathway.
These patterns do not diagnose every cause by themselves, but they help place the problem. For example, a man with infertility and very elevated FSH may have impaired spermatogenesis even if testosterone symptoms are not prominent. A man with low libido, fatigue, and low testosterone but non-elevated LH may need evaluation for secondary hypogonadism, medication effects, obesity-related suppression, or pituitary disease.
This is also where LH and FSH have limits. They do not replace semen analysis. They do not tell you sperm count with precision. They do not fully explain erectile symptoms, libido changes, or fertility potential on their own. A normal LH and FSH pattern does not guarantee normal fertility, and an abnormal pattern still needs clinical context.
Exogenous testosterone complicates interpretation even more. Testosterone therapy can suppress LH and FSH and reduce sperm production, sometimes substantially. That is why these hormones are especially important when evaluating fertility in men who are using or recently stopped testosterone or anabolic agents.
When male symptoms such as low libido, reduced morning erections, infertility, fatigue, or low mood are part of the picture, LH and FSH are often most useful as part of a broader hormone panel, not as isolated screening tools. If that wider picture sounds familiar, this guide to male hormone imbalance symptoms and lab patterns can help connect the results to common real-world complaints.
In men, as in women, LH and FSH are best read as signals about where the reproductive axis is struggling, not as single-number verdicts.
When to test and how to interpret results wisely
The most useful LH and FSH testing starts with a clear clinical question. Without that, even accurate numbers can create more confusion than clarity.
A person might need LH and FSH testing when there is:
- unexplained infertility
- irregular or absent periods
- suspected ovulatory dysfunction
- hot flashes or cycle changes at an unusually young age
- possible primary ovarian insufficiency
- low testosterone symptoms in men
- abnormal semen analysis
- suspected pituitary or hypothalamic dysfunction
The next question is timing. In cycling women, early-follicular testing is often preferred when the goal is baseline interpretation. In amenorrhea, timing may be less about cycle day and more about getting the broader diagnostic picture. In men, morning testosterone is often paired with LH and FSH because testosterone itself has a daily rhythm. In both sexes, repeat testing may matter if results are borderline or do not fit the clinical picture.
A few common interpretation mistakes are worth avoiding:
- Reading one result without knowing cycle day
- Assuming an LH to FSH ratio diagnoses PCOS
- Using FSH alone as a forecast of future natural fertility
- Interpreting labs while on hormonal contraception as if they reflect an unsuppressed cycle
- Ignoring other hormones such as estradiol, testosterone, prolactin, or TSH
- Treating a borderline result as final without repeat testing when the situation is unclear
Symptoms matter too. So do age and medication history. A 26-year-old with missed periods and high FSH is a different problem from a 47-year-old in the menopause transition. A man with low testosterone and suppressed LH after anabolic steroid use is a different problem from someone with high LH and primary testicular failure.
This is why hormone interpretation is less about memorizing normal ranges and more about pattern recognition. It is also why specialist input can save time when the results are conflicting, fertility plans are urgent, or the hormonal picture suggests pituitary, ovarian, or testicular dysfunction beyond a simple screening question. If you are at that stage, it may help to know when hormone results justify endocrine or fertility referral rather than repeated guesswork.
The most balanced way to view LH and FSH is this: they are genuinely useful hormones, but only when they are answering a specific question. When used that way, they can clarify ovulation, gonadal function, and reproductive signaling. When used without context, they are among the easiest reproductive labs to overinterpret.
References
- Markers of ovarian reserve as predictors of future fertility 2023
- Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 (Guideline)
- Current evaluation of amenorrhea: a committee opinion 2024 (Guideline)
- Updates to Male Infertility: AUA/ASRM Guideline (2024) 2024 (Guideline)
- Evidence-based guideline: Premature Ovarian Insufficiency 2025 (Guideline)
Disclaimer
This article is for educational purposes and is not a substitute for personal medical advice, diagnosis, or treatment. LH and FSH results can be affected by cycle timing, age, pregnancy status, hormonal contraception, recent illness, body weight changes, intense exercise, pituitary disorders, and other medications or medical conditions. Fertility and hormone health should not be judged from one lab result alone. Speak with a qualified clinician if you have absent periods, infertility, suspected ovulation problems, low testosterone symptoms, or results that do not match how you feel.
If this article helped you, please share it on Facebook, X (formerly Twitter), or any platform where it may help someone make better sense of confusing hormone results.
